45 results on '"Graham, Danielle L."'
Search Results
2. Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
3. Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
4. Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.
5. Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial
6. Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration
7. Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers
8. Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers
9. Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
10. Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial
11. Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease
12. Regulation of Anxiety and Initiation of Sexual Behavior by CREB in the Nucleus Accumbens
13. Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models
14. Information-Rich, Dual-Function 13C/2H-Isotopic Crosstalk NMR Assay for Human Serine Racemase (hSR) Provides a PLP-Enzyme “Partitioning Fingerprint” and Reveals Disparate Chemotypes for hSR Inhibition
15. College-Going Volition Scale
16. Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial
17. Trial of Cinpanemab in Early Parkinson’s Disease
18. Information-Rich, Dual-Function 13C/2H‑Isotopic Crosstalk NMR Assay for Human Serine Racemase (hSR) Provides a PLP-Enzyme "Partitioning Fingerprint" and Reveals Disparate Chemotypes for hSR Inhibition.
19. Tau-targeting antisense oligonucleotide MAPTRxin mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
20. Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy
21. Characterization of tau binding by gosuranemab
22. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats
23. Quantitative Measurements of LRRK2 in Human Cerebrospinal Fluid Demonstrates Increased Levels in G2019S Patients
24. Striatal regulation of ΔFosB, FosB, and cFos during cocaine self-administration and withdrawal
25. The Effects of Continuous and Intermittent Ethanol Exposure in Adolesence on the Aversive Properties of Ethanol During Adulthood
26. Region-specific tolerance to cocaine-regulated cAMP-dependent protein phosphorylation following chronic self-administration
27. Periadolescent exposure to ethanol and diazepam alters the aversive properties of ethanol in adult mice
28. Human Serine Racemase: Key Residues/Active Site Motifs and Their Relation to Enzyme Function
29. Author Correction: Tau-targeting antisense oligonucleotide MAPTRxin mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
30. ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs
31. Human serine racemase structure/activity relationship studies provide mechanistic insight and point to position 84 as a hot spot for β-elimination function
32. Yohimbine Increases Impulsivity Through Activation of cAMP Response Element Binding in the Orbitofrontal Cortex
33. Environmental Enrichment Produces a Behavioral Phenotype Mediated by Low Cyclic Adenosine Monophosphate Response Element Binding (CREB) Activity in the Nucleus Accumbens
34. Tropomyosin-Related Kinase B in the Mesolimbic Dopamine System: Region-Specific Effects on Cocaine Reward
35. Phosphorylation of GluR1, ERK, and CREB during spontaneous withdrawal from chronic heroin self-administration
36. CREB regulation of nucleus accumbens excitability mediates social isolation–induced behavioral deficits
37. The Influence of ΔFosB in the Nucleus Accumbens on Natural Reward-Related Behavior
38. Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions
39. Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse
40. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats
41. Overexpression ofCREB in the Nucleus Accumbens Shell Increases Cocaine Reinforcement in Self-Administering Rats.
42. Reinforcement-Related Regulation of AMPA Glutamate Receptor Subunits in the Ventral Tegmental Area Enhances Motivation for Cocaine.
43. Information-Rich, Dual-Function 13 C/ 2 H-Isotopic Crosstalk NMR Assay for Human Serine Racemase (hSR) Provides a PLP-Enzyme "Partitioning Fingerprint" and Reveals Disparate Chemotypes for hSR Inhibition.
44. Reinforcement-related regulation of AMPA glutamate receptor subunits in the ventral tegmental area enhances motivation for cocaine.
45. The influence of DeltaFosB in the nucleus accumbens on natural reward-related behavior.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.